RenovoRx, Inc. SEC filings RNXT

RenovoRx, Inc. has 292 filings in SEC EDGAR's recent list, going back to Apr 10, 2013. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

RenovoRx, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Apr 30, 2026 Apr 30, 2026
DEF 14A Proxy statement Apr 30, 2025 Apr 30, 2025
DEF 14A Proxy statement Apr 30, 2024 Apr 30, 2024
DEF 14A Proxy statement Nov 27, 2023 Nov 27, 2023
PRE 14A Preliminary proxy statement Nov 17, 2023 Nov 17, 2023
DEF 14A Proxy statement May 1, 2023 May 1, 2023
DEF 14A Proxy statement Apr 29, 2022 Apr 29, 2022

Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
RNXT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Mountain View, CA
SEC filer status
, Emerging growth company
SEC CIK
1574094

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.